Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    Open Studies | "Hypertriglyceridemia"
Show Display Options
Rank Status Study
21 Recruiting Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
Conditions: Metabolic Syndrome;   Dyslipidemia;   Hypertriglyceridemia
Interventions: Other: Standard reference diet;   Other: Almond supplemented diet;   Other: Low carbohydrate reference diet
22 Recruiting A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
Condition: Hypertriglyceridemia
Interventions: Drug: Drug Omega 3;   Drug: Drug Omega-3 Comparator
23 Unknown  The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients
Conditions: Diabetes Mellitus, Type 2;   Hypercholesterolemia;   Hypertriglyceridemia
Interventions: Drug: Omega-3 acid 4 grams per day;   Drug: Placebo control
24 Recruiting Novel Therapies for Metabolic Complications of Lipodystrophies
Conditions: Insulin Resistance;   Hypertriglyceridemia;   Diabetes;   Hepatic Steatosis
Interventions: Other: low-fat diet  ( Still recruiting );   Other: Diet
25 Unknown  Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
Condition: Hypertriglyceridemia
Interventions: Drug: Diazoxide choline;   Drug: Diazoxide choline high dose
26 Not yet recruiting A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.
Conditions: Non-alcoholic Fatty Liver Disease (NAFLD;   Hypertriglyceridemia
Interventions: Drug: Placebo;   Drug: Omega-3 carboxylic acid;   Drug: Fenofibrate 200mg
27 Unknown  Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
Conditions: Hypertriglyceridaemia;   Familial Hypercholesterolaemia
Interventions: Dietary Supplement: Fish oil capsule;   Drug: HMG Coenzyme reductase
28 Recruiting An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Condition: Severe Hypertriglyceridemia
Interventions: Drug: Epanova;   Drug: Lovaza
29 Unknown  Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
Condition: Coronary Artery Disease
Intervention: Drug: Omacor, omega-3 fatty acids in CAD patients
30 Recruiting Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
Condition: Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions: Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
31 Recruiting Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Untreated Hypertriglyceridemia
Condition: Dyslipidemias
Interventions: Dietary Supplement: Astaxanthin;   Dietary Supplement: Placebo
32 Recruiting Change of Fructose to Fat in South Asians
Conditions: Elevated Triglycerides;   Diabetes;   Cardiovascular Disease;   Dyslipidemia
Intervention: Other: Fructose + Glucose Beverage
33 Unknown  Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia
Condition: Type 2 Diabetes Mellitus ;Obesity,High Triglycerides;TCM
Interventions: Drug: Metformin;   Drug: Jiangtangtiaozhi decoction
34 Recruiting A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Condition: Cardiovascular Diseases
Interventions: Drug: AMR101;   Drug: Placebo
35 Recruiting Short-term Effects of Leptin in People With Lipodystrophy
Condition: Lipodystrophy
Intervention: Biological: Metreleptin
36 Recruiting Causes and Natural History of Dyslipidemias
Condition: Dyslipidemias
Intervention:
37 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
38 Not yet recruiting Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Condition: Type 1 Hyperlipoproteinemia
Interventions: Drug: SLx-4090 placebo;   Drug: Orlistat Placebo;   Drug: Orlistat;   Drug: Slx-4090
39 Recruiting Genes Involved in Lipid Disorders
Condition: Dyslipidemia
Intervention:
40 Recruiting Evaluation of Lipoproteins
Conditions: Hyperlipidemia;   Hyperlipoproteinemia;   Hypolipoproteinemia
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years